Abstract:
This invention concerns tetrahydropyridoindoles of the formula: ##STR1## wherein Q represents ##STR2## in which R. sub. 3 is hydrogen, C. sub. 1-4 alkyl, C. sub. 1-4 alkoxy, or --COO(C. sub. 1-2) alkyl, and n is an integer from 1 to 7; R. sub. 1 is hydrogen, halogen, hydroxy, or C. sub. 1-3 alkyl; and R. sub. 2 is hydrogen, C. sub. 1-4 alkyl or --(CH. sub. 2). sub. m --A where A is --N(CH. sub. 3). sub. 2,--N(C. sub. 2 H. sub. 5). sub. 2, ##STR3## in which Ar is 2-pyrimidinyl, 2-pyrazinyl, phenyl, or phenyl substituted by a methyl, ethyl, methoxy, ethoxy, or trifluoromethyl group; and m is an integer from 1-4, or physiologically acceptable salts thereof, providing however that when n is 1, Q may not be quinolinyl. These compounds exhibit antihypertensive properties. Four of the disclosed compounds also exhibit antipsychotic properties.